{
    "nctId": "NCT00782366",
    "briefTitle": "Predictive Genetic Risk Assessment Trial",
    "officialTitle": "Proof-of-Principle Trial of Communication to Patients Receiving Predictive Genetic Risk Assessment",
    "overallStatus": "COMPLETED",
    "conditions": "Colon Cancer, Lung Cancer, Atrial Fibrillation, Diabetes Type 2, Obesity, Breast Cancer, Graves Disease, Osteoarthritis, Celiac Disease, Myocardial Infarction, Prostate Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 26,
    "primaryOutcomeMeasure": "Assess accessibility and feasibility, including positive and negative aspects of integrating predictive genomics at the clinic focusing on patients' and physicians' attitudes",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* must be established EH patient or physician\n\nExclusion Criteria:\n\n* pregnant women\n* patient who have already purchased Navigenics Health Compass",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}